BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
N Engl J Med
.
2021 May 20;384(20):1968-1970.
doi: 10.1056/NEJMc2104281.
Epub 2021 Apr 21.
Authors
Stefan Roest
1
,
Rogier A S Hoek
1
,
Olivier C Manintveld
1
Affiliation
1
Erasmus MC Transplant Institute, Rotterdam, the Netherlands o.manintveld@erasmusmc.nl.
PMID:
33882226
DOI:
10.1056/NEJMc2104281
No abstract available
Publication types
Letter
Comment
MeSH terms
BNT162 Vaccine
COVID-19 Vaccines*
COVID-19*
Humans
Mass Vaccination
RNA, Messenger
SARS-CoV-2
Substances
COVID-19 Vaccines
RNA, Messenger
BNT162 Vaccine